These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2647628)
1. Interaction of human eosinophils or neutrophils with Trypanosoma cruzi in vitro causes bystander cardiac cell damage. Molina HA; Kierszenbaum F Immunology; 1989 Feb; 66(2):289-95. PubMed ID: 2647628 [TBL] [Abstract][Full Text] [Related]
2. Role of inflammatory cells in Chagas' disease. I. Uptake and mechanism of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human eosinophils. Villalta F; Kierszenbaum F J Immunol; 1984 Apr; 132(4):2053-8. PubMed ID: 6421933 [TBL] [Abstract][Full Text] [Related]
3. Role of polymorphonuclear cells in Chagas' disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human neutrophils. Villalta F; Kierszenbaum F J Immunol; 1983 Sep; 131(3):1504-10. PubMed ID: 6309964 [TBL] [Abstract][Full Text] [Related]
4. Metabolic requirements for the damage of Trypanosoma cruzi epimastigotes by human polymorphonuclear leukocytes. Cardoni RL; Docampo R; Casellas AM J Parasitol; 1982 Aug; 68(4):547-52. PubMed ID: 6288905 [TBL] [Abstract][Full Text] [Related]
5. Eosinophil activation in acute and chronic chagasic myocardial lesions and deposition of toxic eosinophil granule proteins on heart myofibers. Molina HA; Kierszenbaum F J Parasitol; 1989 Feb; 75(1):129-33. PubMed ID: 2918433 [TBL] [Abstract][Full Text] [Related]
6. Role of inflammatory cells in Chagas' disease. III. Kinetics of human eosinophil activation upon interaction with parasites (Trypanosoma cruzi). Kierszenbaum F; Villalta F; Tai PC J Immunol; 1986 Jan; 136(2):662-6. PubMed ID: 3079790 [TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895 [TBL] [Abstract][Full Text] [Related]
8. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. Braun M; de Titto E Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated cytotoxicity to Trypanosoma cruzi. II. Antibody-dependent killing of bloodstream forms by mouse eosinophils and neutrophils. Kipnis TL; James SL; Sher A; David JR Am J Trop Med Hyg; 1981 Jan; 30(1):47-53. PubMed ID: 7011071 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of Trypanosoma cruzi dihydrolipoamide dehydrogenase by leukocyte myeloperoxidase systems: role of hypochloride and nitrite related radicals. Gutiérrez-Correa J; Krauth-Siegel RL; Stoppani AO Rev Argent Microbiol; 2000; 32(3):136-43. PubMed ID: 11008705 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of neural cell adhesion molecule in Chagas' myocarditis. Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of deposits of eosinophil-derived neurotoxin and eosinophil peroxidase in the myocardium of patients with Chagas' disease. Molina HA; Kierszenbaum F Immunology; 1988 Aug; 64(4):725-31. PubMed ID: 3049321 [TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: parasite-induced release of lysosomal enzymes by human polymorphonuclear leukocytes. de Titto EH; Cardoni RL Exp Parasitol; 1983 Oct; 56(2):247-54. PubMed ID: 6413240 [TBL] [Abstract][Full Text] [Related]
14. Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. Molina HA; Kierszenbaum F; Hamann KJ; Gleich GJ Am J Trop Med Hyg; 1988 Mar; 38(2):327-34. PubMed ID: 2451444 [TBL] [Abstract][Full Text] [Related]
15. Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. Wirth JJ; Kierszenbaum F J Immunol; 1985 Mar; 134(3):1989-93. PubMed ID: 2857187 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of development of inflammatory lesions in myocardial and skeletal muscle in experimental Trypanosoma cruzi infection. Molina HA; Kierszenbaum F J Parasitol; 1988 Jun; 74(3):370-4. PubMed ID: 3132546 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of resistance against experimental Trypanosoma cruzi infection. Requirements for cellular destruction of circulating forms of T. cruzi in human and murine in vitro systems. Kierszenbaum F; Hayes MM Immunology; 1980 May; 40(1):61-6. PubMed ID: 6998860 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: sequence of phagocytosis and cytotoxicity by human polymorphonuclear leucocytes. Rimoldi MT; Cardoni RL; Olabuenaga SE; de Bracco MM Immunology; 1981 Apr; 42(4):521-7. PubMed ID: 7016743 [TBL] [Abstract][Full Text] [Related]
20. Stimulatory effects of retinoic acid on macrophage interaction with blood forms of Trypanosoma cruzi: involvement of transglutaminase activity. Wirth JJ; Kierszenbaum F J Immunol; 1986 Nov; 137(10):3326-31. PubMed ID: 2877027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]